Sort
40,608 grants matching “prostate cancer”
Improving Patient Outcomes Through System Navigation
$826,715Peter C Raich · Denver Health And Hospital Authority · U01 · FY2008 · CA
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
$826,363Martin G Sanda · Beth Israel Deaconess Medical Center · U01 · FY2008 · CA
Stress responses in embryonic stem cellsvvvv
$826,339Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (3 of 3)
$826,248Baqar A Husaini · Tennessee State University · U54 · FY2014 · CA
FUSION GENES PREDICT PROSTATE CANCER RECURRENCE
$826,200University Of Wisconsin System · · FY2016 · Department of the Army
Prostate Cancer in a Black Population
$826,045McRistina Leske · State University New York Stony Brook · R01 · FY2008 · CA
PREVENTION OF ALZHEIMER'S BY VITAMIN E AND SELENIUM
$825,816University Of Kentucky · R01 · FY2001 · AG
Targeting Tumor Suppressor Phosphatases For Cancer Therapy
$825,000Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · U01 · FY2009 · CA
INVESTIGATING THE ROLE OF NOVEL TRANSCRIPTS IN THE MYCN LOCUS DRIVING NEUROENDOCRINE PROSTATE CANCER
$824,997Queensland University Of Technology · · FY2022 · Defense Health Agency
A NOVEL TARGETED THERAPY FOR TREATMENT-EMERGENT ANAPLASTIC FORMS OF CASTRATION-RESISTANT PROSTATE CANCER
$824,927Queensland University Of Technology · · FY2022 · Defense Health Agency
Prostate Section
$824,926Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Clinical Fellowship Training Program
$824,926Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2021 · CA
IDENTIFYING GENETIC, TRANSCRIPTIONAL, AND MICROENVIRONMENT DRIVERS OF LETHAL PROSTATE CANCER FOR PATIENT STRATIFICATION, DISEASE TRACKING, AND DRUG TARGET DISCOVERY.
$824,895University Of Melbourne · · FY2021 · Defense Health Agency
DEVELOPMENT OF CLINICAL-GRADE, TARGETED MAGNETIC NANOPARTICLES
$824,860Ralph Weissleder · Massachusetts Institute Of Technology · U54 · FY2009 · CA
High Energy and Spatial Resolution Multi-Isotope SPECT Imaging of Targeted Alpha-Emitters and their Daughters
$824,428George Sgouros · Johns Hopkins University · U01 · FY2024 · EB
T-PHARMACYTES FOR PROSTATE CANCER IMMUNOTHERAPY
$824,347Massachusetts Institute Of Technology · · FY2010 · Department of Defense
Enabling Technologies for MRI-Guided Prostate Interventions
$824,121Clare M Tempany · Brigham And Women'S Hospital · R01 · FY2013 · CA
Role of FH loss in development of HLRCC heriditary kidney cancer
$824,045Leonard Neckers · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction
$824,045Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Missouri Valley Cancer Consortium CCOP
$823,998Missouri Valley Cancer Consortium, Inc. · U10 · FY2004 · CA
INVESTIGATION OF CIRCULATING TUMOR CELL CLUSTERS AS POTENTIAL BIOMARKERS FOR AGGRESSIVE PROSTATE CANCER IN AFRICAN AMERICAN PATIENTS
$823,831Georgia Tech Research Corp · · FY2020 · Defense Health Agency
Stroger Hospital of Cook County, MBCCOP
$823,820Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2011 · CA
GRAPHICAL REPRESENTATIONS OF SYMPTOMS OF PROSTATE CANCER (GRASP): PREFERENCES FOR QUALITY OF LIFE PRESENTATION AMONG UNDERSERVED PROSTATE CANCER PATI
$823,257University Of California, Los Angeles · · FY2018 · Department of the Army
Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer
$822,934Paul Martinetti · Digital Science Technologies, Llc · R42 · FY2010 · CA
Iowa Oncology Research Association
$822,579Robert J. Behrens · Iowa Oncology Research Association · U10 · FY2011 · CA